| Primary |
| Rheumatoid Arthritis |
66.2% |
| Gastritis |
3.5% |
| Hypertension |
3.5% |
| Osteoporosis |
3.2% |
| Ill-defined Disorder |
2.8% |
| Musculoskeletal Pain |
2.8% |
| Upper Respiratory Tract Inflammation |
2.1% |
| Gastric Ulcer |
1.8% |
| Nasopharyngitis |
1.8% |
| Ankylosing Spondylitis |
1.4% |
| Arthralgia |
1.4% |
| Diabetes Mellitus |
1.4% |
| Drug Use For Unknown Indication |
1.4% |
| Caplan's Syndrome |
1.1% |
| Crohn's Disease |
1.1% |
| Exostosis |
1.1% |
| Prophylaxis |
1.1% |
| Renal Failure Chronic |
1.1% |
| Colitis Ulcerative |
0.7% |
| Hypothyroidism |
0.7% |
|
| Rash |
12.7% |
| Pyrexia |
10.9% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
8.2% |
| White Blood Cell Count Decreased |
7.3% |
| Interstitial Lung Disease |
6.4% |
| Drug Eruption |
5.5% |
| Neutropenia |
4.5% |
| Sepsis |
4.5% |
| Tachycardia |
4.5% |
| Vomiting |
4.5% |
| Pancytopenia |
3.6% |
| Platelet Count Decreased |
3.6% |
| Toxic Epidermal Necrolysis |
3.6% |
| Toxic Skin Eruption |
3.6% |
| Glomerulonephritis Membranous |
2.7% |
| Leukoencephalopathy |
2.7% |
| Neutrophil Count Decreased |
2.7% |
| Pneumonia |
2.7% |
| Thrombocytopenia |
2.7% |
| Vasculitis |
2.7% |
|
| Secondary |
| Rheumatoid Arthritis |
60.9% |
| Drug Use For Unknown Indication |
5.9% |
| Juvenile Arthritis |
5.2% |
| Prophylaxis |
3.3% |
| Hypertension |
3.0% |
| Osteoporosis |
2.2% |
| Pancreatitis Chronic |
2.2% |
| Arthralgia |
1.8% |
| Gastritis |
1.8% |
| Antibiotic Prophylaxis |
1.5% |
| Atrial Fibrillation |
1.5% |
| Constipation |
1.5% |
| Diabetes Mellitus |
1.5% |
| Psoriatic Arthropathy |
1.5% |
| Angina Pectoris |
1.1% |
| Cardiac Failure Congestive |
1.1% |
| Epilepsy |
1.1% |
| Lumbar Spinal Stenosis |
1.1% |
| Product Used For Unknown Indication |
1.1% |
| Ankylosing Spondylitis |
0.7% |
|
| Non-hodgkin's Lymphoma |
9.8% |
| Pneumocystis Jiroveci Pneumonia |
9.8% |
| Mycobacterium Avium Complex Infection |
7.3% |
| Petechiae |
7.3% |
| Sepsis |
7.3% |
| Upper Respiratory Tract Inflammation |
7.3% |
| Pneumonia |
4.9% |
| Pneumonitis |
4.9% |
| Pseudomonas Infection |
4.9% |
| Red Blood Cell Count Decreased |
4.9% |
| Rheumatoid Arthritis |
4.9% |
| Sedation |
4.9% |
| Thrombocytopenia |
4.9% |
| Agranulocytosis |
2.4% |
| Atrial Fibrillation |
2.4% |
| Bile Duct Cancer |
2.4% |
| Duodenal Ulcer Haemorrhage |
2.4% |
| Eczema |
2.4% |
| Haemolytic Anaemia |
2.4% |
| Hypoaesthesia |
2.4% |
|
| Concomitant |
| Rheumatoid Arthritis |
59.5% |
| Drug Use For Unknown Indication |
10.4% |
| Prophylaxis |
5.4% |
| Osteoporosis |
3.9% |
| Hypertension |
3.8% |
| Antibiotic Prophylaxis |
2.2% |
| Crohn's Disease |
2.1% |
| Gastritis |
2.1% |
| Psoriatic Arthropathy |
1.3% |
| Gastrointestinal Disorder Therapy |
1.2% |
| Constipation |
1.1% |
| Gastric Ulcer |
1.0% |
| Infection Prophylaxis |
1.0% |
| Insomnia |
1.0% |
| Diabetes Mellitus |
0.8% |
| Bronchitis |
0.8% |
| Psychotic Disorder |
0.7% |
| Premedication |
0.7% |
| Reflux Oesophagitis |
0.7% |
| Osteoporosis Prophylaxis |
0.5% |
|
| Injection Site Pain |
12.1% |
| Pneumocystis Jiroveci Pneumonia |
10.0% |
| Rheumatoid Arthritis |
9.3% |
| Pulmonary Tuberculosis |
8.6% |
| Femur Fracture |
6.4% |
| Pneumonia |
6.4% |
| Urticaria |
5.0% |
| White Blood Cell Count Decreased |
5.0% |
| Rash |
4.3% |
| Gastroenteritis |
3.6% |
| Oedema Peripheral |
3.6% |
| Disseminated Tuberculosis |
2.9% |
| Dysphonia |
2.9% |
| Injection Site Pruritus |
2.9% |
| Injection Site Rash |
2.9% |
| Injection Site Warmth |
2.9% |
| Liver Disorder |
2.9% |
| Pyrexia |
2.9% |
| Stomatitis |
2.9% |
| Therapeutic Response Decreased |
2.9% |
|
| Interacting |
| Rheumatoid Arthritis |
28.6% |
| Hyperlipidaemia |
14.3% |
| Hypertension |
14.3% |
| Hypothyroidism |
14.3% |
| Pain |
14.3% |
| Pulmonary Embolism |
14.3% |
|
| Gastrointestinal Haemorrhage |
100.0% |
|
